Publicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (11)

2021

  1. Correction to: SEOM clinical guidelines for the treatment of head and neck cancer (2020) (Clinical and Translational Oncology, (2021), 23, 5, (913-921), 10.1007/s12094-020-02533-1)

    Clinical and Translational Oncology

  2. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial

    Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 764-772

2018

  1. SEOM clinical guidelines for the treatment of head and neck cancer (2017)

    Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 75-83

2017

  1. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study

    International Journal of Radiation Oncology Biology Physics, Vol. 97, Núm. 3, pp. 473-480

2012

  1. In answer to: "comments to SEOM clinical guidelines for the treatment of thyroid cancer" by Garcilaso Riesco-Eizaguirre et al

    Clinical and Translational Oncology

2011

  1. SEOM clinical guidelines for the treatment of thyroid cancer

    Clinical and Translational Oncology, Vol. 13, Núm. 8, pp. 574-579

2010

  1. Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

    British Journal of Cancer, Vol. 102, Núm. 12, pp. 1687-1691

  2. SEOM clinical guidelines for the treatment of head and neck cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 742-748

  3. SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma

    Clinical and Translational Oncology

2009

  1. Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients

    Clinical and Translational Oncology, Vol. 11, Núm. 11, pp. 727-736

2002

  1. Estudio de la astenia tumoral: Constituci-acon del grupo ASTHENOS

    Revista Clinica Espanola, Vol. 202, Núm. 10, pp. 525-528